Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2026-03-08 @ 11:03 PM
Study NCT ID:
NCT01461928
Status:
COMPLETED
Last Update Posted:
2019-08-06
First Post:
2011-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-19
First Submit QC Date:
None
Study First Post Date:
2011-10-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-31
Results First Submit QC Date:
None
Results First Post Date:
2019-08-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-16
Last Update Post Date:
2019-08-06
Last Update Post Date Type:
ACTUAL